Immune-related adverse events due to checkpoint inhibitors
24:40
Immune Mediated Necrotizing Myopathies IMNM
10:03
Comment ça marche ? (Partie 1/3) Complications dysimmunitaires des inhibiteurs de checkpoint
11:32
Quelle prise en charge des complications dysimmunitaires des inhibiteurs de checkpoint ? Partie 3/3
21:59
Monitoring, managing, and mitigating immune-related adverse events
18:05
Déficits immunitaires par anticorps anticytokines
27:20
Ozempic Devrimi: Yeni Zayıflama İlaçları Mucize mi, Zehir mi?
44:56
Immune Checkpoint Blockade in Cancer Therapy
17:26